1. Home
  2. INTT vs SKYE Comparison

INTT vs SKYE Comparison

Compare INTT & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • SKYE
  • Stock Information
  • Founded
  • INTT 1981
  • SKYE 2012
  • Country
  • INTT United States
  • SKYE United States
  • Employees
  • INTT N/A
  • SKYE N/A
  • Industry
  • INTT Semiconductors
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTT Technology
  • SKYE Health Care
  • Exchange
  • INTT Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • INTT 102.1M
  • SKYE 80.7M
  • IPO Year
  • INTT 1997
  • SKYE N/A
  • Fundamental
  • Price
  • INTT $7.95
  • SKYE $3.20
  • Analyst Decision
  • INTT Strong Buy
  • SKYE Buy
  • Analyst Count
  • INTT 2
  • SKYE 6
  • Target Price
  • INTT $16.00
  • SKYE $18.67
  • AVG Volume (30 Days)
  • INTT 30.9K
  • SKYE 217.3K
  • Earning Date
  • INTT 03-26-2025
  • SKYE 02-25-2025
  • Dividend Yield
  • INTT N/A
  • SKYE N/A
  • EPS Growth
  • INTT N/A
  • SKYE N/A
  • EPS
  • INTT 0.22
  • SKYE N/A
  • Revenue
  • INTT $121,971,000.00
  • SKYE N/A
  • Revenue This Year
  • INTT $7.28
  • SKYE N/A
  • Revenue Next Year
  • INTT $5.39
  • SKYE N/A
  • P/E Ratio
  • INTT $37.04
  • SKYE N/A
  • Revenue Growth
  • INTT N/A
  • SKYE N/A
  • 52 Week Low
  • INTT $6.28
  • SKYE $2.31
  • 52 Week High
  • INTT $14.35
  • SKYE $19.41
  • Technical
  • Relative Strength Index (RSI)
  • INTT 42.05
  • SKYE 51.55
  • Support Level
  • INTT $7.94
  • SKYE $2.60
  • Resistance Level
  • INTT $8.35
  • SKYE $3.54
  • Average True Range (ATR)
  • INTT 0.37
  • SKYE 0.50
  • MACD
  • INTT -0.11
  • SKYE 0.03
  • Stochastic Oscillator
  • INTT 19.02
  • SKYE 30.91

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: